Zhongnan Medical Journal Press

Home Results

A total of 21 result was found. Results that relate to Non-small cell lung cancer

The research progress into long non-coding RNA in non-small cell lung cancer

Published on New Medicine 2023,33(3):228-236.
11185 times 2883 times

Juan WANG Xu HAN Ning ZHAO Hong-Tao GUO Xing LIAO Miao JIANG Hao GU

Non-small cell lung cancer Long non-coding RNA Diagnosis Treatment Prognosis
Details
Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysis

Published on New Medicine 2022,32(1):250-259.
12356 times 3614 times

Ming-Zhen LI Shao-Hua HE Ying-Hui JIN Cheng CHEN Si-Yu YAN Yong-Bo WANG Huan LIU Zhi-Qing ZHOU Han XIAO Rui-Rui YANG Li-Ming TAN

Circulating tumor cell Non-small cell lung cancer Prognosis Meta-analysis
Details
Rapid health technology assessment of anlotinib in treatment of advanced non-small cell lung cancer

Published on New Medicine 2021,31(1):350-356.
15083 times 4077 times

Shan SHEN Jie YANG Yun-Xia LIU Hai-Ming MA Ning HOU

Anlotinib Advanced non-small cell lung cancer Rapid health technology assessment
Details
The effect of lung wedge resection on the surgical parameters and postoperative complications in elderly patients with stage Ib non-small cell lung cancer

Published on Journal of Mathematical Medicine 2023,36(1):36-42.
7944 times 2089 times

Sen LI Guang-Yao MA Xiang-Qun MA Yan-Bing YANG

Non-small cell lung cancer Wedge resection of lung Surgical effect Postoperative complications
Details
A retrospective study on the safety of off-indication use of pyrotinib in patients with non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1238-1242.
7261 times 1947 times

Hao-Chun TANG Jun MENG Zheng-Zheng XIA Ling-Zhi REN

Non-small cell lung cancer Pyrotinib Adverse drug reaction Safety Off-indication
Details
Effect of platinum-containing regimen combined with chemotherapy on the survival of elderly patients with advanced non-small cell lung cancer

Published on Journal of Mathematical Medicine 2023,36(12):899-905.
10863 times 2137 times

Xue-Xing WANG Yuan HE Jie CHU Yu-Feng WANG

Non-small cell lung cancer Retrospective cohort study Chemotherapy The elderly Survival analysis
Details
A network Meta-analysis of efficacy and safety of different administration routes of recombinant human endostatin in the treatment of non-small cell lung cancer with malignant pleural effusion

Published on Frontiers in Pharmaceutical Sciences 2024,27(4):697-710.
9679 times 1725 times

XU Zhuanzhuan TU Chaochao GONG Zhangqin GUO Yingao TU Mingli

Recombinant human endostatin Administration routes Non-small cell lung cancer Malignant pleural effusion Network Meta-analysis Intravenous drip Pleural effusion
Details
A case of intestinal hemorrhage caused by immune enteritis due to sintilimab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):818-823.
10812 times 2179 times

MENG Baowei WU Caizhi MA Yongming CHANG Ruitong YANG Xiaogang TIAN Huashan WU Zhiqiang YIN Rui ZHU Zijiang

Sintilimab Non-small cell lung cancer Immune enteritis Intestinal bleeding Adverse drug reactions
Details
First-line treatment with tislelizumab for advanced non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):790-800.
10999 times 1910 times

LI Wenyan PAN Xiding JIE Qiong LI Yuanyuan TANG Mufei

Tislelizumab Non-small cell lung cancer First-line treatment Rapid health technology assessment
Details
Construction of a nomogram model for the prognosis of advanced non-small cell lung cancer patients treated with microwave ablation combined with immunotherapy based on inflammatory and nutritional indicators

Published on Journal of Mathematical Medicine 2024,37(12):899-911.
12480 times 1865 times

LI Chen XIANG Shiqiang

Non-small cell lung cancer Microwave ablation Immunotherapy Nutritional indicators Inflammatory indicators Nomogram model
Details
Pharmacoeconomic evaluation of third-line treatment of advanced non-small cell lung cancer with anlotinib

Published on Frontiers in Pharmaceutical Sciences 2024,28(4):639-647.
11914 times 1381 times

YUAN Wenjie KANG Shuo WANG Xiaohui GONG Yuan PAN Zhenhua

Anlotinib Pharmacoeconomics Non-small cell lung cancer Cost-utility analysis
Details
Clinical efficacy analysis of cross-line immunotherapy in driver gene-negative advanced non-small cell lung cancer patients

Published on New Medicine 2025,35(2):151-161.
11217 times 1944 times

WANG Yuankun LU Jiahao HU Jing XIE Conghua

Cross-line immunotherapy Non-small cell lung cancer Immune checkpoint inhibitors Prognosis Driver gene-negative
Details
Analysis of influencing factors of cisplatin chemotherapy sensitivity and construction of nomogram model in elderly patients with non-small cell lung cancer

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):284-290.
8575 times 1143 times

HE Ting CHEN Jingjing LI Yuling

Elderly Non-small cell lung cancer Cisplatin Chemotherapy sensitivity Influencing factors Nomogram model Predictive efficiency
Details
Mechanism of Salvia miltiorrhiza against non-small cell lung cancer based on network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2025,29(3):361-373.
6907 times 1374 times

TAO Gan GUO Xiuli HE Fajian WU Qiuji ZHONG Yahua

Salvia miltiorrhiza Traditional Chinese medicine Network pharmacology Molecular docking Non-small cell lung cancer
Details
Efficacy and safety of Tislelizumab combined with chemotherapy in the treatment of non-small cell lung cancer: a Meta-analysis

Published on New Medicine 2025,35(4):442-451.
10414 times 1823 times

WANG Kuan TAN Xiao GUO Yanni

Non-small cell lung cancer Tislelizumab Chemotherapy Effectiveness Safety Meta-analysis
Details